During the forecast period 2023 to 2033, the Atrophic vaginitis treatment market is expected to grow at a value of 8% CAGR, according to Future Market Insights. By the year 2033, the global market for Atrophic vaginitis treatment is expected to rise up to a market valuation of US$ 6 Billion. The atrophic vaginitis treatment market is expected to grow significantly in the coming years due to the increasing prevalence of the condition.
According to a report published by the National Institutes of Health, approximately 50% of women experience vaginal dryness and discomfort after menopause, and around 10-40% of these women experience atrophic vaginitis. This translates to millions of women who are in need of proper treatment.
The market offers various treatment options, including hormone replacement therapy, topical estrogen creams, and vaginal moisturizers. Hormone replacement therapy is one of the most effective treatments for atrophic vaginitis. It involves taking hormones to replace the estrogen that the body is no longer producing. This treatment has been proven to reduce symptoms such as vaginal dryness, itching, and painful intercourse.
Download a sample to obtain additional highlights and key points on various market segments and their impact in the coming years @
https://www.futuremarketinsights.com/reports/sample/rep-gb-16831
Topical estrogen creams are another popular treatment option. These creams are applied directly to the vagina and help to restore the natural moisture and elasticity of the vaginal tissues. They are easy to use and have been shown to be effective in relieving symptoms. Thus, with the availability of effective treatments, the atrophic vaginitis market is expected to grow in the upcoming years.
Key Takeaways from the Market Study
- The global Atrophic vaginitis treatment market is expected to grow with an 8% CAGR during 2023 to 2033.
- By therapy type, Estrogen based therapy are expected to hold 53% of the market share in 2023 for Atrophic vaginitis treatment market.
- North America is expected to possess 48% market share for Atrophic vaginitis treatment market in 2023.
- Europe Atrophic vaginitis treatment market size is expected to possess 43% market share in 2023.
“The atrophic vaginitis treatment market is revolutionizing women’s health by providing effective solutions to a common condition that affects millions of women worldwide. With the increasing prevalence of the condition, the market is expected to grow significantly in the coming years. Despite the challenges faced by the industry” states an FMI analyst
Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16831
Competitive Landscape
Key players in the atrophic vaginitis treatment are Shionogi, Duchesnay, Hormos Medical, QuatRx Pharmaceuticals, Pantarhei Bioscience, Mithra Pharmaceuticals, AMAG Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc, Theramex, Endoceutics, Inc.
- Shionogi is a pharmaceutical company that has developed a treatment for atrophic vaginitis called Intrarosa (prasterone). Intrarosa is a vaginal insert that contains the hormone dehydroepiandrosterone (DHEA), which is converted into estrogen in the body.
- Bayer HealthCare Pharmaceuticals Inc, a key player in the atrophic vaginitis treatment market is focusing on developing treatments for the ailment by researching and investing in developing therapies.
More Valuable Insights
Future Market Insights, in its new offering, presents an unbiased analysis of the global Atrophic vaginitis treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis of Diagnosis (Pelvic exam, Urine test, Acid balance test) Treatment (Vaginal moisturizers and Water-based lubricants) Therapy Type (Estrogen based drugs and Non-estrogen based drugs) Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)
Grow your profit margin with Future Market Insights – Buy the report@ https://www.futuremarketinsights.com/checkout/16831
Key Segments Profiled in the Atrophic Vaginitis Treatment Industry Survey
Diagnosis:
- Pelvic exam
- Urine test
- Acid balance test
Treatment:
- Vaginal moisturizers
- Water-based lubricants
Therapy Type:
- Estrogen based drugs
- Non-estrogen based drugs
Distribution Channel:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Have a Look at Related Research Reports in the Healthcare Domain:
Point-of-Care Diagnostics Market Trend: According to Future Market Insights research, during the projected period, the Global point-of-care diagnostics market is expected to grow at a CAGR of 6.8%. The market value is projected to increase from US$ 38.7 Billion in 2023 to US$ 74.8 Billion by 2033.
Hypoparathyroidism Treatment Market Forecast: The global hypoparathyroidism treatment market was valued at US$ 777.4 million as of 2022 and is likely to reach US$ 841.9 million in 2023. During the 2023 to 2033 forecast period, the market is expected to incline at a CAGR of 7.7%, and is expected to total US$ 1,767.4 million by the end of the said period of assessment.
Neonatal Thermoregulation Market Analysis: The global neonatal thermoregulation market is estimated at US$ 661.8 million in 2023. The market is projected to reach US$ 1,151.6 million by 2033, exhibiting a CAGR of 5.7% from 2023 to 2033.
About FMI:
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs